A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

By Yoshida Tsutomu  

Supportive Care in Cancer, Vol. 17, Iss. 3, 2009-03 ,pp. : 315-320

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer

By Soetekouw Patricia   Timmer-Bonte Johanna   Drift Miep   Leeuwen Frank   Wagenaar Michiel   Die Lya   Bussink Jan   Tjan-Heijnen Vivianne  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 988-996

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

By Tomonaga Nanae   Nakamura Yoichi   Soda Hiroshi   Nagashima Seiji   Nakano Hirofumi   Kinoshita Akitoshi   Fukuda Masaaki   Fukuda Minoru   Takatani Hiroshi   Soejima Yoshifumi   Oka Mikio   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 43-49

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

By Ono Yasushi   Hino Mitsunori   Ueda Yuka   Kamizuru Ryoko   Omata Masatoshi   Uehara Takashi   Tanaka Yosuke   Soma Tomoyuki   Kudoh Shoji  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 402-406

Humana Press, Inc

Access to resources Recommend Favorite